Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Antimicrobial Agents and Chemotherapy
|
July 1, 1991
Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital
D N Gerding, T A Larson, R A Hughes, et al.
AIDS Patient Care and Stds
|
November 2, 2001
Evaluation of the impact and acceptance of a nutrition program in an HIV community clinic
R L Brunner, T A Larson, B J Scott, et al.
Oncogene
|
December 1, 1994
T cell tumours of disparate phenotype in mice transgenic for Rbtn-2
R C Larson, P Fisch, T A Larson, et al.
Pharmacotherapy
|
January 1, 1995
Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases
R E Seay, T A Larson, J P Toscano, et al.
Evaluation & the Health Professions
|
November 7, 2000
Key elements for implementing comprehensive health care models for persons with HIV: a stakeholder analysis
L A Melchior, A T Panter, T A Larson, et al.
Pharmaceutical Research
|
July 1, 1992
An in vitro pharmacodynamic model to simulate antibiotic behavior of acute otitis media with effusion
K Vance-Bryan, T A Larson, M W Garrison, et al.
The EMBO Journal
|
March 1, 1996
Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice
R C Larson, I Lavenir, T A Larson, et al.
Annals of Emergency Medicine
|
February 1, 1994
Indomethacin suppositories versus intravenously titrated morphine for the treatment of ureteral colic
W H Cordell, T A Larson, J E Lingeman, et al.
AIDS Patient Care and Stds
|
May 22, 2001
Building comprehensive HIV/AIDS care services
K L Meredith, T A Larson, K R Soons, et al.
Cell
|
June 14, 1996
An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes
J Corral, I Lavenir, H Impey, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Antimicrobial Agents and Chemotherapy
|
July 1, 1991
Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital
D N Gerding, T A Larson, R A Hughes, et al.
AIDS Patient Care and Stds
|
November 2, 2001
Evaluation of the impact and acceptance of a nutrition program in an HIV community clinic
R L Brunner, T A Larson, B J Scott, et al.
Oncogene
|
December 1, 1994
T cell tumours of disparate phenotype in mice transgenic for Rbtn-2
R C Larson, P Fisch, T A Larson, et al.
Pharmacotherapy
|
January 1, 1995
Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases
R E Seay, T A Larson, J P Toscano, et al.
Evaluation & the Health Professions
|
November 7, 2000
Key elements for implementing comprehensive health care models for persons with HIV: a stakeholder analysis
L A Melchior, A T Panter, T A Larson, et al.
Pharmaceutical Research
|
July 1, 1992
An in vitro pharmacodynamic model to simulate antibiotic behavior of acute otitis media with effusion
K Vance-Bryan, T A Larson, M W Garrison, et al.
The EMBO Journal
|
March 1, 1996
Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice
R C Larson, I Lavenir, T A Larson, et al.
Annals of Emergency Medicine
|
February 1, 1994
Indomethacin suppositories versus intravenously titrated morphine for the treatment of ureteral colic
W H Cordell, T A Larson, J E Lingeman, et al.
AIDS Patient Care and Stds
|
May 22, 2001
Building comprehensive HIV/AIDS care services
K L Meredith, T A Larson, K R Soons, et al.
Cell
|
June 14, 1996
An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes
J Corral, I Lavenir, H Impey, et al.
Page
of 4